Home
Versant Venture Capital VI reported a 1.1% stake in Tempest Therapeutics TPST · 162,972 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 1.1%
- Last report
- 3.7% · filed 25/08/13
- Shares held
- 162,972 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 26/03/30
- Filed
- 26/04/02
1.1% stake · below 5%
- Stake
- 1.1%
- Last report
- 3.7%
- Since last report
- −2.6pp
Tempest Therapeutics trades, last 26 weeks
What else happened in Tempest Therapeutics around then
Filed or reported within 30 days of the trade day · 02/28~04/29Versant Venture Capital VI's other 5% stake reports
- Versant Venture Capital VI
5% stakeMonte Rosa Therapeutics
5% stakeMonte Rosa Therapeutics
GLUE
3.4% stake
2,236,708 sh
3.4% stake
Filed 01/09
- Versant Venture Capital VI
5% stakeMonte Rosa Therapeutics
5% stakeMonte Rosa Therapeutics
GLUE
5.1% stake
3,334,669 sh
5.1% stake
Filed 25/11/12
- Versant Venture Capital VI
5% stakeLenz Therapeutics
5% stakeLenz Therapeutics
LENZ
3.4% stake
1,050,599 sh
3.4% stake
Filed 25/11/10
- Versant Venture Capital VI
5% stakeLenz Therapeutics
5% stakeLenz Therapeutics
LENZ
4.1% stake
1,183,543 sh
4.1% stake
Filed 25/09/22
- Versant Venture Capital VI
5% stakeLenz Therapeutics
5% stakeLenz Therapeutics
LENZ
4.9% stake
1,400,220 sh
4.9% stake
Filed 25/08/20
